Clairity Welcomes Jeffrey Luber as New CEO to Drive Growth
Clairity Appoints Jeffrey R. Luber as CEO Company Poised to Revolutionize Breast Cancer Screening through AI-based Risk Prediction Clairity, Inc., a pioneer in AI-driven predictive tools for breast cancer, has officially announced the appointment of Jeffrey R. Luber, JD, MBA, as President, Chief Executive Officer, and Director. With extensive experience in oncology,...
Continue Reading